Muramyl dipeptide
- Availability: 24/48H Stock Items & 2 to 6 Weeks non Stock Items.
- Dry Ice Shipment: No


Muramyl dipeptide
Description :
Muramyl dipeptide (MDP) is a synthetic immunoreactive peptide, consisting of N-acetyl muramic acid attached to a short amino acid chain of L-Ala-D-isoGln. Muramyl dipeptide is an inducer of bone formation through induction of Runx2. Muramyl dipeptide directly enhances osteoblast differentiation by up-regulating Runx2 gene expression through MAPK pathways. Muramyl dipeptide is a NLRP1 agonist[1][2].Product Name Alternative :
MDPUNSPSC :
12352211Hazard Statement :
H315, H319Target :
NOD-like Receptor (NLR) ; p38 MAPKType :
Reference compoundRelated Pathways :
Immunology/Inflammation; MAPK/ERK PathwayApplications :
COVID-19-immunoregulationField of Research :
Inflammation/Immunology; CancerAssay Protocol :
https://www.medchemexpress.com/muramyl-dipeptide.htmlConcentration :
10mMPurity :
98.0Solubility :
DMSO : 100 mg/mL (ultrasonic) |H2O : 50 mg/mL (ultrasonic)Smiles :
CC(N[C@@H](C=O)[C@H]([C@H](O)[C@H](O)CO)O[C@H](C)C(N[C@@H](C)C(N[C@@H](C(N)=O)CCC(O)=O)=O)=O)=OMolecular Formula :
C19H32N4O11Molecular Weight :
492.48Precautions :
H315, H319References & Citations :
[1]Park OJ, et al. Muramyl Dipeptide, a Shared Structural Motif of Peptidoglycans, Is a Novel Inducer of Bone Formation through Induction of Runx2. J Bone Miner Res. 2017 Jul;32 (7) :1455-1468.|[2]V Kaushal, et al. Neuronal NLRP1 inflammasome activation of Caspase-1 coordinately regulates inflammatory interleukin-1-beta production and axonal degeneration-associated Caspase-6 activation. Cell Death Differ. 2015 Oct;22 (10) :1676-86.Shipping Conditions :
Blue IceStorage Conditions :
-20°C, 3 years (Powder)Scientific Category :
Reference compound1Clinical Information :
Phase 3Isoform :
NLRP1; p38 MAPKCAS Number :
[53678-77-6]

